Effect of Modified Air-pulse Stimulation on Tracheotomised Patients With Dysphagia After Stroke

Launched by THE SECOND AFFILIATED HOSPITAL OF DALIAN MEDICAL UNIVERSITY · Mar 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment method to help patients who have difficulty swallowing, known as dysphagia, after having a stroke and who also have a tracheotomy (a procedure where a hole is made in the neck to help with breathing). The goal is to see if a special type of air-pulse stimulation, delivered through a flexible endoscope, can improve their swallowing ability compared to a traditional method. The study will involve 42 patients who are recovering from a stroke, and they will be divided into two groups: one will receive the new treatment while the other will continue with the standard care.

To participate in this trial, individuals must be between the ages of 30 and 80, have a confirmed diagnosis of stroke, and have stable vital signs. They should also not have had swallowing problems before the stroke. Participants can expect to receive personalized swallowing rehabilitation training, and their progress will be monitored using several tests that check their swallowing ability and overall health. Importantly, the trial is currently recruiting participants, and anyone interested should discuss this opportunity with their healthcare provider for more information.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients who met the diagnostic criteria for stroke formulated in the 4th National Academic Conference on Cerebrovascular disease;
• • patients with relatively stable vital signs, with a NIHSS score of 21 points;
• • patients with tracheotomy accompanied by dysphagia;
• • no previous history of dysphagia;
• • age ≥ 30 years and ≤80 years;
• • informed consent signed by the patient and his family.
• Exclusion Criteria:
• • patients with medullary haemorrhage/infarction;
• • patients that experienced cerebral hernia and recurrent stroke;
• • patients with unstable arrhythmia, fever, infection, severe restlessness and inability to cooperate with treatment;
• • patients with gastro-oesophageal reflux, bilateral paralysis of the vocal cord, laryngopharyngeal stenosis/haemorrhage/tumour;
• • patients in which there was an inability to accurately locate epiglottis and arytenoid cartilage due to throat disease;
• • patients with a history of epilepsy or risk of seizures.